Takeda Pharmaceutical (TAK) News Today → We’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How) (From Paradigm Press) (Ad) Free TAK Stock Alerts $13.46 -0.07 (-0.52%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 7 at 9:15 AM | globenewswire.comCeliac Disease Market and Epidemiology Analysis 2018-2034 with Detailed Profiles of Marketed and Pipeline Drugs, Including KAN-101 (Kanyos Bio) and TIMP-GLIA/TAK 101 (Takeda)June 6 at 10:33 AM | marketbeat.comCapital Research Global Investors Acquires 503,446 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Capital Research Global Investors boosted its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 3.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,297,805 shares of thJune 6 at 6:19 AM | seekingalpha.comTakeda: Strong Growth Catalysts And Maturing Pipeline Continue To Limit Downside RiskJune 3, 2024 | businesswire.comTakeda's TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to PlaceboJune 1, 2024 | marketbeat.comGold Investment Management Ltd. Makes New $994,000 Investment in Takeda Pharmaceutical Company Limited (NYSE:TAK)Gold Investment Management Ltd. bought a new position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 69,664 shares of the compJune 1, 2024 | businesswire.comTakeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin LymphomaMay 31, 2024 | businesswire.comTakeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)May 30, 2024 | marketbeat.comPNC Financial Services Group Inc. Sells 255,384 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)PNC Financial Services Group Inc. reduced its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 78.1% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 71,732 shares of the company's stock aftMay 29, 2024 | msn.comTakeda is planning hundreds of layoffs in MassachusettsMay 29, 2024 | finance.yahoo.comTakeda Pharmaceuticals layoff plan follows $1.87 million in Massachusetts tax incentivesMay 25, 2024 | msn.comDrug giant Takeda plans more than 640 layoffs in MassachusettsMay 20, 2024 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Bought by Brandes Investment Partners LPBrandes Investment Partners LP grew its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 47.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,651,265 shares of the cMay 20, 2024 | seekingalpha.comWeek In Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion DealMay 16, 2024 | finance.yahoo.comTakeda Canada Inc. concludes Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for LIVTENCITY® (maribavir) for the treatment of adults with a post-transplant cytomegalovirus (CMV) infectionMay 14, 2024 | finance.yahoo.comScilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent DisputeMay 14, 2024 | finance.yahoo.comUpdate: Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent DisputeMay 14, 2024 | businesswire.comTakeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual MeetingMay 13, 2024 | businesswire.comAC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's DiseaseMay 13, 2024 | bizjournals.comMeet the Mass. life science CEOs with the largest pay packagesMay 9, 2024 | finance.yahoo.comJapan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%May 9, 2024 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Reaches New 1-Year Low at $12.77Takeda Pharmaceutical (NYSE:TAK) Hits New 12-Month Low at $12.77May 9, 2024 | seekingalpha.comTakeda Pharmaceutical Company Limited 2023 Q4 - Results - Earnings Call PresentationMay 9, 2024 | investorplace.comTAK Stock Earnings: Takeda Pharmaceutical Reported Results for Q4 2023May 9, 2024 | reuters.comJapan's Takeda Pharma says full-year profit slumps 56%May 8, 2024 | forbes.comA Five-Pillar Process To Develop Sales LeadersMay 8, 2024 | marketwatch.comTakeda Pharmaceutical's Fourth-Quarter Profit Expected to Have More Than Tripled -- Earnings PreviewMay 2, 2024 | marketbeat.comTakeda Pharmaceutical (TAK) Set to Announce Earnings on ThursdayTakeda Pharmaceutical (NYSE:TAK) will be releasing earnings before the market opens on Thursday, May 9, Zacks reports.May 1, 2024 | marketbeat.comY.D. More Investments Ltd Has $17.90 Million Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Y.D. More Investments Ltd cut its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 9.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,254,591 shares of the company'April 30, 2024 | finance.yahoo.comBeacon Biosignals and Takeda Launch Strategic Collaboration to Advance Neurobiomarkers and Endpoints for Sleep DisordersApril 30, 2024 | marketbeat.comabrdn plc Takes Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)abrdn plc purchased a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 105,073 shares of the compaApril 27, 2024 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Short Interest Down 26.5% in AprilTakeda Pharmaceutical Company Limited (NYSE:TAK - Get Free Report) was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 5,970,000 shares, a decrease of 26.5% from the March 31st total of 8,120,000 shares. Based on an average daily volume of 1,850,000 shares, the days-to-cover ratio is presently 3.2 days. Currently, 0.2% of the company's stock are short sold.April 26, 2024 | markets.businessinsider.comTakeda Reports Positive CHMP Opinion For Fruquintinib - Quick FactsApril 26, 2024 | businesswire.comTakeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal CancerApril 26, 2024 | marketbeat.comFederated Hermes Inc. Has $6.26 Million Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)Federated Hermes Inc. reduced its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 22.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 438,324 shares of the company's stock after selling 125,449 shares during the period. FederatedApril 25, 2024 | msn.comTakeda said to have left industry trade group BIOApril 25, 2024 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Reaches New 12-Month Low at $13.08Takeda Pharmaceutical (NYSE:TAK) Hits New 12-Month Low at $13.08April 24, 2024 | msn.comJapan’s SMBC joins JV to support drug discovery start-upsApril 23, 2024 | finance.yahoo.comNeurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive DisorderApril 22, 2024 | prnewswire.comTakeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery ProgramsApril 19, 2024 | benzinga.comExploring The Competitive Space: Eli Lilly and Co Versus Industry Peers In PharmaceuticalsApril 18, 2024 | finance.yahoo.comU.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s DiseaseApril 18, 2024 | businesswire.comU.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's DiseaseApril 16, 2024 | finance.yahoo.comTakeda Pharmaceutical Company Limited (4502.T)April 15, 2024 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Hits New 52-Week Low at $13.19Takeda Pharmaceutical (NYSE:TAK) Hits New 1-Year Low at $13.19April 8, 2024 | businesswire.comTakeda Announces New U.S. Corporate Social Responsibility Program Partners to Build Equity through STEM Education and Access to Nutritional FoodApril 6, 2024 | marketbeat.comPacer Advisors Inc. Sells 897,979 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Pacer Advisors Inc. lessened its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 96.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 28,766 shares of the company's stock after selling 8April 4, 2024 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) is XY Capital Ltd's 3rd Largest PositionXY Capital Ltd increased its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 432.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 765,137 shares of the company's stock after buying anApril 2, 2024 | businesswire.comOncoinvent Announces Changes to its Board of Directors and Formation of Scientific and Clinical Advisory BoardApril 1, 2024 | finance.yahoo.comAculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEOMarch 28, 2024 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Trading Down 2.4%Takeda Pharmaceutical (NYSE:TAK) Stock Price Down 2.4% Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address We’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How) (Ad)Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from these levels. But there are at least 10 different coins that I like even better. TAK Media Mentions By Week TAK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TAK News Sentiment▼0.590.73▲Average Medical News Sentiment TAK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TAK Articles This Week▼65▲TAK Articles Average Week Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PFE News Today VRTX News Today SNY News Today REGN News Today GSK News Today BMY News Today ZTS News Today ALNY News Today TEVA News Today GMAB News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TAK) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored